Williopsis saturnus yeast killer toxin does not kill Streptococcus pneumoniae

Irma Ochigava, Phillip J. Collier, Graeme M. Walker, Regine Hakenbeck

Research output: Contribution to journalArticle

  • 3 Citations

Abstract

Streptococcus pneumoniae is an important human bacterial pathogen, and the increase in antibiotic resistance demands the development of new antimicrobial compounds. Several reports have suggested that yeast killer toxins show activity against bacteria and we therefore investigated the activity of K9 killer toxin from the yeast Williopsis saturnus var. mrakii NCYC 500 against S. pneumoniae. However, no inhibition of bacterial growth was observed with concentrated K9 preparations in agar diffusion assays and in liquid culture. Although cell morphology was slightly affected by K9 treatment, no effect on cellular viability was detectable, and K9 had no stimulatory effect on cell lysis induced by β-lactams or Triton X-100. This indicated that K9 did not contribute to cell wall damage. Moreover, flow cytometry was used as a sensitive assessment of integrity of cells exposed to killer toxin. No significant damage of S. pneumoniae cells was evident, although minor changes in fluorescence suggested that K9 killer toxin may interact with bacterial surface components.
Original languageEnglish
Pages (from-to)559–566
Number of pages8
JournalAntonie van Leeuwenhoek
Volume99
Issue number3
DOIs
StatePublished - Mar 2011

Fingerprint

Williopsis
Yeast Killer Factor
Streptococcus pneumoniae
Octoxynol
beta-Lactams
Microbial Drug Resistance
Cell Wall
Agar
Flow Cytometry
Fluorescence
Bacteria

Cite this

Ochigava, Irma; Collier, Phillip J.; Walker, Graeme M.; Hakenbeck, Regine / Williopsis saturnus yeast killer toxin does not kill Streptococcus pneumoniae.

In: Antonie van Leeuwenhoek, Vol. 99, No. 3, 03.2011, p. 559–566.

Research output: Contribution to journalArticle

@article{0888f95ef10a4c5b80391df01bc54f00,
title = "Williopsis saturnus yeast killer toxin does not kill Streptococcus pneumoniae",
abstract = "Streptococcus pneumoniae is an important human bacterial pathogen, and the increase in antibiotic resistance demands the development of new antimicrobial compounds. Several reports have suggested that yeast killer toxins show activity against bacteria and we therefore investigated the activity of K9 killer toxin from the yeast Williopsis saturnus var. mrakii NCYC 500 against S. pneumoniae. However, no inhibition of bacterial growth was observed with concentrated K9 preparations in agar diffusion assays and in liquid culture. Although cell morphology was slightly affected by K9 treatment, no effect on cellular viability was detectable, and K9 had no stimulatory effect on cell lysis induced by β-lactams or Triton X-100. This indicated that K9 did not contribute to cell wall damage. Moreover, flow cytometry was used as a sensitive assessment of integrity of cells exposed to killer toxin. No significant damage of S. pneumoniae cells was evident, although minor changes in fluorescence suggested that K9 killer toxin may interact with bacterial surface components.",
author = "Irma Ochigava and Collier, {Phillip J.} and Walker, {Graeme M.} and Regine Hakenbeck",
year = "2011",
month = "3",
doi = "10.1007/s10482-010-9524-3",
volume = "99",
pages = "559–566",
journal = "Antonie van Leeuwenhoek",
issn = "0003-6072",
publisher = "Springer Netherlands",
number = "3",

}

Williopsis saturnus yeast killer toxin does not kill Streptococcus pneumoniae. / Ochigava, Irma; Collier, Phillip J.; Walker, Graeme M.; Hakenbeck, Regine.

In: Antonie van Leeuwenhoek, Vol. 99, No. 3, 03.2011, p. 559–566.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Williopsis saturnus yeast killer toxin does not kill Streptococcus pneumoniae

AU - Ochigava,Irma

AU - Collier,Phillip J.

AU - Walker,Graeme M.

AU - Hakenbeck,Regine

PY - 2011/3

Y1 - 2011/3

N2 - Streptococcus pneumoniae is an important human bacterial pathogen, and the increase in antibiotic resistance demands the development of new antimicrobial compounds. Several reports have suggested that yeast killer toxins show activity against bacteria and we therefore investigated the activity of K9 killer toxin from the yeast Williopsis saturnus var. mrakii NCYC 500 against S. pneumoniae. However, no inhibition of bacterial growth was observed with concentrated K9 preparations in agar diffusion assays and in liquid culture. Although cell morphology was slightly affected by K9 treatment, no effect on cellular viability was detectable, and K9 had no stimulatory effect on cell lysis induced by β-lactams or Triton X-100. This indicated that K9 did not contribute to cell wall damage. Moreover, flow cytometry was used as a sensitive assessment of integrity of cells exposed to killer toxin. No significant damage of S. pneumoniae cells was evident, although minor changes in fluorescence suggested that K9 killer toxin may interact with bacterial surface components.

AB - Streptococcus pneumoniae is an important human bacterial pathogen, and the increase in antibiotic resistance demands the development of new antimicrobial compounds. Several reports have suggested that yeast killer toxins show activity against bacteria and we therefore investigated the activity of K9 killer toxin from the yeast Williopsis saturnus var. mrakii NCYC 500 against S. pneumoniae. However, no inhibition of bacterial growth was observed with concentrated K9 preparations in agar diffusion assays and in liquid culture. Although cell morphology was slightly affected by K9 treatment, no effect on cellular viability was detectable, and K9 had no stimulatory effect on cell lysis induced by β-lactams or Triton X-100. This indicated that K9 did not contribute to cell wall damage. Moreover, flow cytometry was used as a sensitive assessment of integrity of cells exposed to killer toxin. No significant damage of S. pneumoniae cells was evident, although minor changes in fluorescence suggested that K9 killer toxin may interact with bacterial surface components.

U2 - 10.1007/s10482-010-9524-3

DO - 10.1007/s10482-010-9524-3

M3 - Article

VL - 99

SP - 559

EP - 566

JO - Antonie van Leeuwenhoek

T2 - Antonie van Leeuwenhoek

JF - Antonie van Leeuwenhoek

SN - 0003-6072

IS - 3

ER -